Our observation, both in the discovery-replication analysis and with MR analysis, that NT-proBNP and BNP act as two associated biomarkers for individuals at a heightened risk of future fragility fractures discloses a likely shared pathogenic pathway between fractures and cardiovascular disease. This evidence concerns the gene NPPB and cardiovascular disorder.